Novo Nordisk Scraps New Danish Factory Plans
10 Articles
10 Articles
Novo Nordisk scraps new Danish factory plans
Danish pharmaceuticals giant Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, said on Wednesday it was abandoning plans for a new factory in Denmark to make drugs for rare diseases, citing "shifts in global demand".
According to Novo Nordisk, employees will be laid off as a result of dropped plans for production in Odense.
Several hundred new jobs were planned at Novo Nordisk, which is building a large production plant in Tietgenbyen in Odense.
The pharmaceutical company Novo Nordisk was supposed to create several hundred jobs at the new location in Odense. The post Novo Nordisk is putting production plans in Odense on ice first appeared on Nordisch.info.
Novo Nordisk halts Funen production for storage use - more than 50 percent of staff cut - The Copenhagen Post
Novo Nordisk is halting plans for production facilities in Odense. The site currently under construction will instead be used for storage and warehousing. According to Jesper Trebbien Andersen, head of the facilities, this decision reflects responsible capacity planning based on the current market situation and global demand. The change will result in layoffs for more […]
The country's largest company, Novo Nordisk, is putting plans for further development of a production facility in Odense on hold. This is according to site manager Jesper Trebbien Andersen from Novo Nordisk.\- We will continue construction in Odense, but after construction is complete, the facility will function as a warehouse and storage facility instead...
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium






